Guidelines from the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) recommend the use of BNP or NT-proBNP as a class I indication in the diagnosis of heart failure in ambulatory patients with dyspnea [20] however, limited number of studies have been performed on the cost-effectiveness of BNP [21]. Here, NPPB is linked to heart failure.